RFB-25335-13229
1 vaccination
3 coded responses
13 check-ins
3 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 326 / FL
- Registered
- 2020-12-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-29
Dose 1 — Moderna
-
2020-12-30
Registered in v-safe
-
2020-12-30
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Chills, Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2020-12-30
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-06
- 2021-01-12
- 2021-01-15
-
2021-01-19
Survey response — day 21, dose 1MedDRA: Arthralgia, Exposure during pregnancy, Hypertension — Feeling: Poor · Be unable to work, Be unable to do your normal daily activitiesFree text: Hypertension and Polyarthralgias. Seeing rheumatologist/ID specialist for further work up. No prior history to vaccines. Received Tdap exactly 14 days from SARS-CoV2 vax and onset next day. 31 weeks pregnant.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-19
Report sent to call center — day 21, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-26
Survey response — day 28, dose 1MedDRA: Hypertension, Pregnancy — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Moderate to severe hypertension requiring admission to hospital during 3rd trimester.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-26
Report sent to call center — day 28, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-04
Survey response — day 35, dose 1MedDRA: Pre-eclampsia — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Worsening severe preeclampsiaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-04
Report sent to call center — day 35, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-11
- 2021-02-26
- 2021-03-30
- 2021-06-29
- 2021-12-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-29 | Moderna |
Call center
4 call center cases
4 unsuccessful
Free text
Release 2 — day 21, dose 1
Symptoms: Hypertension and Polyarthralgias. Seeing rheumatologist/ID specialist for further work up. No prior history to vaccines. Received Tdap exactly 14 days from SARS-CoV2 vax and onset next day. 31 weeks pregnant.
Release 2 — day 28, dose 1
Symptoms: Moderate to severe hypertension requiring admission to hospital during 3rd trimester.
Release 3 — day 35, dose 1
Symptoms: Worsening severe preeclampsia
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Exposure during pregnancy | ✓ | ✓ | ✓ |
| SD | Hypertension | ✓ | ✓ | ✓ |
| SD | Pre-eclampsia | ✓ | ✓ | ✓ |
| SD | Pregnancy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release